ATN 064: IMMUNOGENICITY, SAFETY, TOLERABILITY, AND BEHAVIORAL CONSEQUENCES OF

ATN 064：免疫原性、安全性、耐受性和行为后果

• 批准号: 8167298
• 负责人: LAWRENCE James D'ANGELO
• 金额: $ 0.63万
• 依托单位: CHILDREN'S RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-01-20 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8167298
• 关键词: Behavioral; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Human Papilloma Virus Vaccine; Institution; Phase; Research; Research Personnel; Resources; Safety; Source; United States National Institutes of Health; Vaccination; Woman; immunogenic; immunogenicity; open label; risk perception; sex risk

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objectives of this phase II, open-label, multi-center study are to determine whether the quadrivalent HPV vaccine is immunogenic, safe, and well-tolerated in 16- to 23-year-old HIV-infected young women, and to examine whether vaccination impacts their perceptions of risk and sexual behaviors.

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项第二阶段开放标签多中心研究的目标是确定四价HPV疫苗在16至23岁感染艾滋病毒的年轻女性中是否具有免疫原性、安全性和良好的耐受性，并检查疫苗接种是否影响她们的风险意识和性行为。